Evidence map›Paper›PMID 25561728›Full record

ArticleThe Journal of biological chemistry2015

Mechanism-based proteomic screening identifies targets of thioredoxin-like proteins.

Lia S Nakao, Robert A Everley, Stefano M Marino, Sze M Lo, Luiz E de Souza, Steven P Gygi, Vadim N Gladyshev

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Biological and Catalytic Properties of Selenoproteins.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lia S NakaoFrom the Division of Genetics, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, the Universidade Federal do Paraná, Departamento de Patologia Básica, 81531-980, Curitiba, PR, Brazil, and.
Robert A Everleythe Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115.
Stefano M MarinoFrom the Division of Genetics, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115.
Sze M Lothe Universidade Federal do Paraná, Departamento de Patologia Básica, 81531-980, Curitiba, PR, Brazil, and.
Luiz E de Souzathe Universidade Federal do Paraná, Departamento de Patologia Básica, 81531-980, Curitiba, PR, Brazil, and.
Steven P Gygithe Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115.
Vadim N GladyshevFrom the Division of Genetics, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, vgladyshev@rics.bwh.harvard.edu.
Brigham and Women's Hospital · USHarvard University · USUniversidade Federal do Paraná · BR

Funding

Functions of thioredoxin reductases and their targetsR37GM065204 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2011 to 2020
$4.0M
Functions of Mammalian Thioredoxin ReductasesR01GM065204 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2002 to 2009
$2.2M
NIGMS NIH HHS GM065204NIGMS NIH HHS R01 GM065204NIGMS NIH HHS R37 GM065204
6 · The paper itself

Abstract

Thioredoxin (Trx)-fold proteins are protagonists of numerous cellular pathways that are subject to thiol-based redox control. The best characterized regulator of thiols in proteins is Trx1 itself, which together with thioredoxin reductase 1 (TR1) and peroxiredoxins (Prxs) comprises a key redox regulatory system in mammalian cells. However, there are numerous other Trx-like proteins, whose functions and redox interactors are unknown. It is also unclear if the principles of Trx1-based redox control apply to these proteins. Here, we employed a proteomic strategy to four Trx-like proteins containing CXXC motifs, namely Trx1, Rdx12, Trx-like protein 1 (Txnl1) and nucleoredoxin 1 (Nrx1), whose cellular targets were trapped in vivo using mutant Trx-like proteins, under conditions of low endogenous expression of these proteins. Prxs were detected as key redox targets of Trx1, but this approach also supported the detection of TR1, which is the Trx1 reductant, as well as mitochondrial intermembrane proteins AIF and Mia40. In addition, glutathione peroxidase 4 was found to be a Rdx12 redox target. In contrast, no redox targets of Txnl1 and Nrx1 could be detected, suggesting that their CXXC motifs do not engage in mixed disulfides with cellular proteins. For some Trx-like proteins, the method allowed distinguishing redox and non-redox interactions. Parallel, comparative analyses of multiple thiol oxidoreductases revealed differences in the functions of their CXXC motifs, providing important insights into thiol-based redox control of cellular processes.

Indexed as

Apoptosis Inducing FactorBinding SitesBlotting, WesternChromatography, LiquidHEK293 CellsHeLa CellsHumansMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsNuclear ProteinsOxidation-ReductionOxidoreductasesProtein BindingProteomeProteomicsRecombinant ProteinsAIFM1 protein, humanApoptosis Inducing FactorCHCHD4 protein, humanMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsNuclear ProteinsnucleoredoxinOxidoreductasesProteomeRecombinant ProteinsThioredoxinsTXNL1 protein, humanTXN protein, humanMammalOxidation-reduction (Redox)ProteomicsRedox RegulationSelenocysteineThiolThioredoxinThioredoxin Reductase

Identifiers

PMID25561728
PMCPMC4342480
OpenAlexW2097565612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.